Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,065 public trials 1,848 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Active, not recruiting

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

NCT05479812

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +37 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, not recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

NCT05239143

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +66 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 14 locations
View Trial Details
Active, not recruiting

A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer

NCT02152631

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • St. Bernards Medical Center Jonesboro, Arkansas, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California - San Diego La Jolla, California, United States
View all 231 locations
View Trial Details
Active, not recruiting

Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED)

NCT04884282

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Institut Sainte Catherine Avignon, France
  • Centre Hospitalier de Cholet Cholet, France
  • GHR Mulhouse Sud Alsace - Hôpital Emile Muller Mulhouse, France
  • Nouvel Hôpital Civil - Hopitaux Universitaires de Strasbourg Strasbourg, France
View all 23 locations
View Trial Details
Active, not recruiting

Clinician-Patient Communication in Lung Cancer Care

NCT02732834

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent and follow-up only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and follow-up only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and follow-up only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Consent and follow-up only) Commack, New York, United States
View Trial Details

Related conditions